Myasthenia gravis: vizsgálatok itt: India

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Bangalore, Hyderabad, Mangalore, Nashik, Pune

  Életkor

  18 év and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00